USPTO serial 99051997
HALOZYME
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- GEARHART, DAVID JAMES
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with HALOZYME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*
Plus Government fees of $750
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gene K. Park
Gene K. Park Morgan, Lewis & Bockius LLPOne Market, Spear Street TowerSan Francisco, CA 94105United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; enzymes for medical purposes, namely, for facilitating delivery of fluids or pharmaceuticals; drug delivery agents consisting of pharmaceuticals containing enzymes that facilitate delivery of fluids and a wide range of pharmaceuticals; pharmaceutical preparations for use in the treatment and prevention of metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, dermatological conditions and disorders, and for the treatment of cancer and in hydration; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in aesthetic skin treatments; Hyaluronic acid for pharmaceutical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures; enzymes for medical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures | ACTIVE | — |
| 035 | Administration of a discount program enabling patients to obtain discounts on prescription drugs through use of a discount card provided by a copay discount program; business administration of a program enabling patients to obtain discounts on prescription drugs through a cash-pay program for uninsured and underinsured patients | ACTIVE | — |
| 036 | Insurance benefits verification and prior authorization assistance in the health industry; copay assistance programs, namely, providing financial assistance to uninsured and underinsured patients for prescription medications | ACTIVE | — |
| 042 | Scientific research and development services for the integration of technologies, therapies, and other systems for pharmaceuticals and drug delivery systems | ACTIVE | — |
| 044 | Providing medical information in the field of subcutaneous fluid administration; providing medical information in the field of subcutaneous delivery of a wide range of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Halozyme, Inc.
- Other trademarks owned by Halozyme, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named HALOZYME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 11, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 10, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 10, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 10, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 13, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 18, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 18, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 12, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 21, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 21, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 21, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 21, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 21, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 7, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 29, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 24, 2025 | NWAP | NEW APPLICATION ENTERED | — |
| Feb 21, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |